Results 241 to 250 of about 3,735,339 (297)

Innovations in the Treatment of Antibiotic-Resistant Infections in Internal Medicine. [PDF]

Cureus
Almeida S, Neves PM, Da Silva Domingues V.   +2 more
europepmc   +1 more source

BCS2.0: a capture sequencing platform for rapid differential diagnosis of bacterial infections and antimicrobial resistance. [PDF]

Front Microbiol
Ranjan A, Guo C, Briese T, Donovan W, Kapoor V, Chandrasekaran A, Mansukhani MM, Berry GJ, Lipkin WI.   +8 more
europepmc   +1 more source

Residual confounding and outcome definition in observational comparisons of PDR-<i>Acinetobacter baumannii</i> therapies. [PDF]

Antimicrob Agents Chemother
Külls C, Dadashpour N, Golestanieraghi M.   +2 more
europepmc   +1 more source

Prevalence and phenotypic characterization of carbapenem resistance in multidrug-resistant Gram-negative bacteria across selected healthcare facilities in the United Arab Emirates: a retrospective study. [PDF]

BMC Infect Dis
Aljaede RAM, Beshir SA, Jaber AAS, Elkalmi R, Ali ESAG, Khedr AHM, ALHamed D, Meera J, AlDeesi Z.   +8 more
europepmc   +1 more source

Acinetobacter Infections in Neonates

Current Infectious Disease Reports, 2018
MDR-Gram-negative bacteria are a great concern in the neonatal population, with a worldwide rise in the reported incidence and with very limited therapeutic options. Acinetobacter baumannii is responsible for many infections in neonates and outbreaks in neonatal intensive care unit (NICU); also, outbreaks caused by other Acinetobacter species have been
Raffaele Zarrilli, Maria Bagattini, Eliana Pia Esposito, Maria Triassi   +3 more
semanticscholar   +6 more sources

Some of the next articles are maybe not open access.

Related searches:

Treatment of Acinetobacter infections

Expert Opinion on Investigational Drugs, 1997
Gram-negative non-fermentative aerobic bacilli are becoming increasingly more involved in nosocomial infections. It has generally been recognised that the members of the Acinetobacter genus are among the most common agents responsible for severe hospital infections; their clinical importance has increased due to the development of antibacterial ...
E Bergogne-Berezin
exaly   +3 more sources